HLA and antibiotic allergic skin eruption

Area of Science:

• Immunogenetics
• Pharmacogenomics
• Dermatology

Background:

• Cutaneous adverse drug reactions (cADRs) are common, posing a significant clinical challenge.
• Genetic factors, particularly human leukocyte antigen (HLA) alleles, are implicated in cADR susceptibility.
• Understanding these genetic associations can aid in predicting and preventing severe reactions.

Purpose of the Study:

• To investigate the association between specific HLA alleles and antibiotic-induced cutaneous eruptions in a Chinese population.
• To identify potential genetic markers for predicting the risk of developing skin reactions to antibiotics.

Main Methods:

• Case-control study design.
• Genotyping of HLA alleles in patients experiencing antibiotic-induced cutaneous eruptions and healthy controls.
• Statistical analysis to determine relative risks (RR) and confidence intervals (CI) for significant associations.

Main Results:

• A positive association was observed between HLA-BW46 and antibiotic-induced cutaneous eruptions (RR = 2.5; 95% CI 1.2-4.9).
• A negative association was found between HLA-B40 and these reactions (RR = 0.46; 95% CI 0.22-0.98).
• The association with HLA-BW46 was notably stronger in patients with ampicillin sensitivity (RR = 3.5; 95% CI 1.4-9.0).

Conclusions:

• Specific HLA alleles, particularly HLA-BW46, are associated with an increased risk of antibiotic-induced cutaneous eruptions in Chinese patients.
• HLA-B40 may confer a protective effect against such reactions.
• These findings highlight the role of immunogenetics in antibiotic hypersensitivity and suggest potential for genetic screening.